Pfizer/BioNTech show high immune response in a booster dose against Omicron in clinical trial for children 5-11 years

Article

Pfizer/BioNTech announce positive results for a third dose of their COVID-19 vaccine for children

Grant Paulsen, MD, assistant professor, Division of Infectious Disease, Department of Pediatrics, Cincinnati Children's Hospital Medical Center in Ohio, and primary investigator for the hospital's clinical trial for a third dose (booster) for the Pfizer/BioNTech vaccine for COVID-19, discusses what the data might mean for children aged 5 to 11 years.

Related Videos
Rupa Wong, MD | Image Credit: Rupa Wong, MD
Tina Tan, MD, FAAP, FIDSA, FPIDS, editor in chief, Contemporary Pediatrics, professor of pediatrics, Feinberg School of Medicine, Northwestern University, pediatric infectious diseases attending, Ann & Robert H. Lurie Children's Hospital of Chicago
John Bradley, MD
Related Content
Contemporary Pediatrics week in review: FDA approved sickle cell treatments, pediatric pneumonia, and more

Contemporary Pediatrics week in review: FDA approved sickle cell treatments, pediatric pneumonia, and more

December 9th 2023
Article

Review some of the top stories from the Contemporary Pediatrics website over the last week, and catch up on anything you may have missed.

What's going on with polio, monkeypox, and COVID-19

What's going on with polio, monkeypox, and COVID-19

August 19th 2022
Podcast

The news is full of stories about monkeypox, the recent changes to COVID-19 guidance, and the return of polio cases. What do clinicians need to know?

Image Credit: Contemporary Pediatrics, Contagion, and Contemporary OB/GYN

RSV Roundtable: What clinicians are witnessing in terms of RSV incidence

December 8th 2023
Article

Last year’s historic RSV season left many wondering if this was going to become a recurring trend. Physicians weigh in on what they are seeing at their institutions in terms of infection rates.

What Omicron could mean for the pandemic

What Omicron could mean for the pandemic

January 7th 2022
Podcast

Contemporary Pediatrics sat down with Tina Q. Tan, MD, FAAP, FIDSA, FPIDS, to discuss what's known about the variant. She also discusses the latest on the vaccine for children aged younger than 5 years.

World’s first chikungunya vaccine FDA approved for individuals 18 years and up | Image Credit: © syahrir - © syahrir - stock.adobe.com.

World’s first chikungunya vaccine FDA approved for individuals 18 years and up

November 10th 2023
Article

The US approval makes VLA1553 (Ixchiq; Valneva) the world’s first licensed chikungunya vaccine.

FDA grants De Novo clearance to Owlet’s Dream Sock: © Andrey - stock.adobe.com

FDA grants De Novo clearance to Owlet’s Dream Sock

November 9th 2023
Article

This decision makes Owlet’s Dream Sock the first and only over-the-counter medical-grade pulse oximeter that is cleared for use in infants, according to the company.

© 2023 MJH Life Sciences

All rights reserved.